Logo image of FOE

FERRO CORP (FOE) Stock Fundamental Analysis

NYSE:FOE - New York Stock Exchange, Inc. - US3154051003 - Common Stock

22.01  +0.06 (+0.27%)

After market: 22.01 0 (0%)

Fundamental Rating

2

Taking everything into account, FOE scores 2 out of 10 in our fundamental rating. FOE was compared to 85 industry peers in the Chemicals industry. FOE may be in some trouble as it scores bad on both profitability and health. FOE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FOE was profitable.
FOE Yearly Net Income VS EBIT VS OCF VS FCFFOE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M -50M 100M 150M

1.2 Ratios

Industry RankSector Rank
ROA 11.54%
ROE 27.65%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FOE Yearly ROA, ROE, ROICFOE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 20

1.3 Margins

Industry RankSector Rank
OM 11.26%
PM (TTM) 13.22%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FOE Yearly Profit, Operating, Gross MarginsFOE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for FOE has been increased compared to 1 year ago.
Compared to 1 year ago, FOE has an improved debt to assets ratio.
FOE Yearly Shares OutstandingFOE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
FOE Yearly Total Debt VS Total AssetsFOE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

2.2 Solvency

FOE has an Altman-Z score of 3.42. This indicates that FOE is financially healthy and has little risk of bankruptcy at the moment.
FOE has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z 3.42
ROIC/WACCN/A
WACCN/A
FOE Yearly LT Debt VS Equity VS FCFFOE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.77 indicates that FOE should not have too much problems paying its short term obligations.
FOE has a Quick Ratio of 1.77. This is a bad value and indicates that FOE is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 0.91
FOE Yearly Current Assets VS Current LiabilitesFOE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.66% over the past year.
FOE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.75% yearly.
The Revenue has grown by 17.45% in the past year. This is quite good.
FOE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.33% yearly.
EPS 1Y (TTM)53.66%
EPS 3Y-5.65%
EPS 5Y2.75%
EPS Q2Q%20%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y1.57%
Revenue growth 5Y-0.33%
Sales Q2Q%2.44%

3.2 Future

The Earnings Per Share is expected to grow by 6.16% on average over the next years.
FOE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.15% yearly.
EPS Next Y-3.81%
EPS Next 2Y5.93%
EPS Next 3Y5.91%
EPS Next 5Y6.16%
Revenue Next Year3.86%
Revenue Next 2Y3.41%
Revenue Next 3Y3.07%
Revenue Next 5Y3.15%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FOE Yearly Revenue VS EstimatesFOE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
FOE Yearly EPS VS EstimatesFOE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.47 indicates a rather expensive valuation of FOE.
When comparing the Price/Earnings ratio of FOE to the average of the S&P500 Index (27.45), we can say FOE is valued slightly cheaper.
The Price/Forward Earnings ratio is 18.16, which indicates a rather expensive current valuation of FOE.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, FOE is valued at the same level.
Industry RankSector Rank
PE 17.47
Fwd PE 18.16
FOE Price Earnings VS Forward Price EarningsFOE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.15
FOE Per share dataFOE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)6.34
EPS Next 2Y5.93%
EPS Next 3Y5.91%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FOE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FERRO CORP

NYSE:FOE (4/21/2022, 8:04:00 PM)

After market: 22.01 0 (0%)

22.01

+0.06 (+0.27%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-01 2022-03-01/amc
Earnings (Next)05-09 2022-05-09/amc
Inst Owners1.3%
Inst Owner Change0%
Ins Owners0.46%
Ins Owner Change0%
Market Cap1.84B
Analysts46
Price Target22.44 (1.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.47
Fwd PE 18.16
P/S 1.63
P/FCF N/A
P/OCF N/A
P/B 3.42
P/tB N/A
EV/EBITDA 12.15
EPS(TTM)1.26
EY5.72%
EPS(NY)1.21
Fwd EY5.51%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS13.47
BVpS6.44
TBVpSN/A
PEG (NY)N/A
PEG (5Y)6.34
Profitability
Industry RankSector Rank
ROA 11.54%
ROE 27.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 11.26%
PM (TTM) 13.22%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 0.91
Altman-Z 3.42
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.66%
EPS 3Y-5.65%
EPS 5Y2.75%
EPS Q2Q%20%
EPS Next Y-3.81%
EPS Next 2Y5.93%
EPS Next 3Y5.91%
EPS Next 5Y6.16%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y1.57%
Revenue growth 5Y-0.33%
Sales Q2Q%2.44%
Revenue Next Year3.86%
Revenue Next 2Y3.41%
Revenue Next 3Y3.07%
Revenue Next 5Y3.15%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A